Alkermes is a biopharmaceutical company that researches, develops, and commercializes pharmaceutical medicines for central nervous system diseases.
Business Model:
Revenue: $1.1B
Employees: 1,001-5,000
Alkermes was acquired by
Recro Pharma.
The acquisition happend on 2015-04-13.
Details of the transaction were not public
Address: 1 Burlington Road
City: Dublin
State: county westmeath
Zip:
Country: IE
Alkermes is a biopharmaceutical company that researches, develops, and commercializes pharmaceutical medicines for central nervous system diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/26/1991
Ticker Symbol:
ALKS
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2013 | Civitas Therapeutics | Series B | 0 |
8/2014 | Civitas Therapeutics | Series C | 0 |
8/2014 | Civitas Therapeutics | Series C | 0 |
9/2013 | Civitas Therapeutics | Series B | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2017 | Post-IPO Equity | 1 | - |
Primecap Management Primecap Management Primecap Management Primecap Management |
1/2014 | Post-IPO Equity | 1 | $250M |
Invesco Invesco |
7/1991 | IPO | - | 12/2017 | Post-IPO Equity | - |
Primecap Management Primecap Management |
7/1991 | IPO | - | 11/2017 | Post-IPO Equity | 1 | - |
Primecap Management Primecap Management Primecap Management Primecap Management |
---|
Announced Date | Name | Price |
---|---|---|
11/2019 | Rodin Therapeutics | |
7/1999 | Advanced Inhalation Research | |
1/1993 | Enzytech |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|